Tag: study

0 0 0 Comment
Posted in HEADLINES

MacroGenics stock falls after study shows breast-cancer survival rates for drug didn’t surpass standard treatment

MacroGenics Inc. MGNX, -3.20% shares dropped late Tuesday after the biotech drug developer said its breast-cancer treatment didn’t perform as…

0 0 0 Comment
Posted in HEADLINES

JAMA study: Ivermectin doesn’t speed up recovery for patients with mild COVID-19

New research indicates that ivermectin, a type of treatment for parasitic worms, does not help patients with mild COVID-19 recover…

0 0 0 Comment
Posted in HEADLINES

New NIH study says the coronavirus was present in five states in December 2019

A new study conducted by the federal government indicates that people in several U.S. states were infected with SARS-CoV-2 in…

0 0 0 Comment
Posted in HEADLINES

U.S. government to study allergic reactions to COVID-19 vaccines

The National Institutes of Health said Wednesday that it started a clinical study assessing allergic reactions to the mRNA COVID-19…

0 0 0 Comment
Posted in HEADLINES

FibroGen stock drops as biotech clarifies data classification in study data

FibroGen Inc. FGEN, -2.78% shares fell in the extended session Tuesday after the biotech drug maker said an analysis of…

0 0 0 Comment
Posted in HEADLINES

NIH to study three experimental COVID-19 treatments

The National Institutes of Health said Thursday that it is putting three more investigational COVID-19 treatments into Phase 2/3 clinical…

0 0 0 Comment
Posted in HEADLINES

Vaxart’s stock falls 42% after disclosing preliminary results from early-stage COVID-19 vaccine study

Shares of Vaxart Inc. VXRT, +49.84% tumbled 42.9% in premarket trading on Wednesday after the company said its oral COVID-19…

0 0 0 Comment
Posted in HEADLINES

Alexion Pharma pauses further enrollment in COVID-19 drug study

Alexion Pharmaceuticals Inc. ALXN, +0.55% said late Wednesday it stopped enrolling patients in a clinical study testing a treatment for…

0 0 0 Comment
Posted in HEADLINES

Biogen’s stock is up 5% after Lilly reports positive data from an Alzheimer’s study

Shares of Biogen Inc. BIIB, +6.07% gained 5.6% in trading on Monday after another drugmaker shared positive clinical data about…

0 0 0 Comment
Posted in HEADLINES

Supernus stock surges after ADHD-drug study results

Supernus Pharmaceuticals Inc. SUPN, +0.45% shares jumped more than 20% in after-hours trading Tuesday after the company revealed positive results…

0 0 0 Comment
Posted in HEADLINES

AstraZeneca study finds its COVID-19 vaccine effective, with one regimen showing 90% efficacy

AstraZeneca AZN, +2.35% AZN, -1.90% said its COVID-19 vaccine candidate met its primary endpoint showing protection from COVID-19 occurring 14…

0 0 0 Comment
Posted in HEADLINES

Remdesivir didn’t reduce mortality among COVID-19 in WHO study: Report

A clinical trial reportedly found that Gilead Sciences Inc.’s GILD, -1.70% COVID-19 treatment remdesivir had no impact on survival in…